The Advantages of Combining Therapies in Treating Psychiatric Patients
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Psychiatric Diseases".
Deadline for manuscript submissions: closed (3 March 2024) | Viewed by 11282
Special Issue Editor
Interests: comorbidity and dual diagnosis in psychiatry; psychopharmacology; attachment theory; social and cultural factors in mental health
Special Issue Information
Dear Colleagues,
Existing treatment modalities in psychiatry, whether biological or psychosocial in nature, are not universally effective. A wide range of variations are observed in the response to these treatments, from complete symptomatic remission to non-response. Due to this, there has been a growing interest in combining different modalities of treatment, both within and across these classes, to optimize mental health outcomes and cost-effectiveness while minimizing adverse events. Recent research has shed light on genetic, biological, and psychosocial factors that may help in predicting treatment response. The purpose of the current Special Issue is to highlight both existing knowledge and cutting-edge research in this field. Both original research and well-conducted reviews on various forms of combined treatment in psychiatry, covering issues such as the efficacy, safety, and prediction of treatment outcomes, will be considered for publication. Emphasis will be placed on work that is innovative in nature and that has well-defined implications for clinical practice or future research in this field.
Dr. Ravi Philip Rajkumar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psychopharmacology
- psychotherapy
- neuromodulation
- combined therapy
- polypharmacy
- polytherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.